0->Consider the problem of assessing semantic entailment connections between distinct sections of Clinical Trial Reports (CTRs) and statements put forth by clinical domain experts. To establish entailment, statements should be supported by the CTR information, not contradicting any of the provided descriptions. In brief, CTRs elucidate the procedures and findings of clinical trials, encompassing four sections: (1) ELIGIBILITY CRITERIA specifying conditions for patient inclusion, (2) INTERVENTION detailing treatments from different patient cohorts, (3) RESULTS summarizing the participant statistics and the trial outcomes, and (4) ADVERSE EVENTS listing observed signs and symptoms. Statements make claims about the information within these sections, either for a single CTR or comparing two CTRs.
----------
1->Evaluate the semantic relationships between various Clinical Trial Reports (CTRs) and expert statements in the clinical field. Ensure that expert claims are substantiated by the CTR content and do not conflict with the report details. CTRs provide insights into clinical trials, divided into four parts: (1) Eligibility Criteria for patient selection, (2) Interventions for different groups, (3) Results with participant data and outcomes, and (4) Recorded Adverse Events. Assess whether statements pertain to individual CTRs or compare findings between two CTRs.
----------
2->Evaluate the semantic relationships between various Clinical Trial Reports (CTRs) and expert statements in the clinical field. Ensure that expert claims are substantiated by the CTR content and do not conflict with the report details. CTRs provide insights into clinical trials, divided into four parts: (1) Eligibility Criteria for patient selection, (2) Interventions for different groups, (3) Results with participant data and outcomes, and (4) Recorded Adverse Events. Analyze claims related to a single CTR or between two CTRs.
----------
3->Examine the semantic links between Clinical Trial Reports (CTRs) and authoritative clinical opinions. CTRs encapsulate trial protocols and results for assessing new therapies
----------
